# TRILIPIX
> **NDA022224** · New Drug Application · Sponsor: ABBVIE · Approved 2008-12-15
## Drug
- **FDA Application Number:** NDA022224
- **Application type:** New Drug Application
- **Brand name:** TRILIPIX
- **Generic name:** FENOFIBRIC ACID
- **Active ingredients:** CHOLINE FENOFIBRATE
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ABBVIE
- **Manufacturer:** Amneal Pharmaceuticals of New York LLC
- **First approval:** 2008-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022224)
---
*MORVS · CC0 1.0*